Member Info for JustHereForHemo

I expect todays rise will have caught some "Long term holders" off guard and they will be bricking it right now!
You just cannot expect the SP to remain bargain basement low while you chase rainbows elsewhere and expect to get in where you left off. IMO without news we have still a long way to go. With news... Forget about it.

@Porky, I would be inclined to agree with you if Hemogenyx was a one trick pony or in bed with a single mistress but the fact is Hemo is far more diverse than any other pre-clinical pharma I have seen.
Eli Lilly have already validated CDX so we can almost discount failure.
Penn have expressed a sign of confidence in signing up to bring HEMO-CAR-T to clinical readiness.
The mice, Lupus, CDX for ALL, HuPHEC......
I would also agree that the money issue is a big concern with most small pharma however Vlad has sidestepped this issue, Hemo is not sinking cash into CDX, if they stopped all operations tomorrow and just proceeded with CDX that one pipeline alone is self funding and will be worth 100s of millions. The CAR-T work with Penn is also sponsored by the Parker Institute.

So Failure though running out of cash? Very unlikely
Failure though proven not to work? Again very unlikely they are not in the development/prove it works in a lab pre-clinical stage, that is done and CDX works, they are now negotiating on licence.

I am very comfortable holding these shares, I have a good chunk from 1.8p and have been happy to average up ever since.

@Micky, yes sure the SP will spike on Eli deal, and it will fall back a little but unless the licence is a few mil up front and then nothing it will never fall back to where it is now. A licencing deal will have milestone payments and agreed royalties when it gets to market, investors will be looking at that and deciding to take a long term position, not just buying for a few days hoping to bag and sell on news as soon as they see a red dot.

"At this stage, our talks with universities have centered around adding classroom space"

What happened to the talks about care homes on campus? Shelved until after covid?

I am looking forward to watching the new Borat movie tomorrow

And as Lunus1 often says: "As You Slide Down The Banister Of Life May The Splinters Never Point The Wrong Way"

Sir Marc is busy bee...
https://www.prnewswire.co.uk/news-releases/in-pursuit-of-the-elusive-drug-the-billion-dollar-blockbuster-800542858.html
Now if he does the same for Hemogenyx....

Just wanted to point out that we have jumped just shy of 12% based on Vlad being happy and tweeting an upbeat message with no reference to hemogenyx, eli, CDX, covid or anything.

So Vlad tweets an upbeat message and SP jumps 12% based on a few of his subscribers on twitter reacting positively.
Now just imagine what happens if an RNS drops.

Said it before, this is not a share for traders, the float is too small, can you make 5-10% here and there? Sure but can you buy in when news drops BEFORE it goes into orbit? What do you think?

Hey Night_Watch, good move mate! Tullow is "Boomin" as you say :-D
Since you left Hemo doing fantastic, I hope nobody jumped on your bandwagon cross ramp and followed you here...

Cant fault them, like your fella night watch or whatever, he did his research and Tullow was err.. "Boomin'" You really cant get much better validation than that!

I agree little penguin :-)
When a director who is speaking to Vlad turns around and says things are going well and on track you can but take him at his word. Likewise half-year reports were positive, brokers note was positive. As of yet no negative results or failures or bad news of any kind.

So basically on track to progress/update in the very near future (EOY 2020) AT LEAST:
HEMO-CAR-T
CDX for AML
Covid project

Big players have not laughed at this tiny company and walked away, they have spent years working in secret with them...

I really dont get why people are treating this like a trading stock, yes so far we have not had that ground breaking news of a licencing deal/buy out for CDX, no take over etc. But the fact remains, any single project in the pipeline at Hemogenyx could be the first one to be bought up or licenced any day, it does not have to be Eli Lilly. Look at the numbers, this is not an oil rig, its not a clothing brand making sweaters, its not a restaurant chain, its a small cap Pharma targeting SEVERAL multi billion pound per year target markets.

Our mCap is 40m. At some point in the very near future either Eli Lilly will sign that first licencing agreement and they will likely pay peanuts compared to what they plan to make when they get to market. Eli are looking to spend 1->5 Billion this year PER DEAL, in takeovers licencing deals and acquisitions etc.... They could buy Hemogenyx 100 times over for that and own everything.
https://www.cnbc.com/2020/01/17/eli-lilly-targets-quarterly-deals-of-1-billion-to-5-billion-in-2020-cfo-says.html

As Vlad has said "Biotech is measured in years and $Billions, not in days and $hundreds."

This is not a trading stock, the potential upside is so massive that you dont want to see it spike on rumour or FOMO. When the right deal lands the % gain will make any profits made on a day to day basis skimming off the <5% profits irrelevant but with the risk that the RNS lands when your taking your daily %

Likewise this is Pharma, its value is on its IP, not in bricks and mortar, not in oil in the ground or precious metals. It has no value if that IP is not worth millions and billions. If you dont believe in Hemogenyx and Vlad and the work they are doing, and you dont believe they will succeed and licence with eli or some other global pharma then you should absolutely not invest, this is either one of the biggest opportunities available right now or its a junk stock, you decide.

@Tuan I think that is BS plenty of us believe in Hemogenyx and the work Vlad is doing. It is nice to make lots of money off the back and in support of life saving research. I would not have a warm fuzzy feeling investing in oil or tobacco etc. While some will sell out the first good rise they get, many of us are eager to stay to the end and see where Hemo goes. Will some of us miss peaks and spikes? Ofcourse but in the end Hemo will be taken over and when that happens the SP paid will be >= that spike so why worry about it?

I am 2.5m now Shuggy lol, ty!

I really would not try and persuade "knowledgeable investors" like night watch to stay in Hemo. He clearly has done his research and Tullow is "Boomin'". What a loss to the Hemogenyx shareholder gene pool, no real need to engage.
The quieter this board gets and the less share holders like night_watch/pumpkin etc that we have the better IMO, they just want their 5-10%.

I said that as a remote possibility, perhaps Hemo are really doing Covid 100% solo and wont have anything to next year and all the nay-Sayers are right :P

I dont believe that for a second, I believe Hemo are working with someone, or rather they developed something and its now with someone for testing/validation/production etc. Point was the SP is not pricing in any covid developments. Hell SP is not pricing in SAFE-HEMO-CAR-T or imminent CDX licencing...

Regarding the CDX deal, yes even the Brokers note and Vlads earlier views make it clear there will be a substantial upfront payment (compared to Hemo MCap atleast). Lots of people seem to be playing chicken here, I really do hope that Eli and Hemo dont leave it to the last minute.

He has been proven correct so far with regards to the direction of travel of Covid19 so he clearly understands and has a plan.
But the lack of feedback means that we have to trust and back Vlad or dont.

Looking at the SP the majority just dont seem to be backing Vlad which is a shame, however great for new investors. I would be nervous if Covid was the only play on the table here but its not, its only a small piece of the Hemo pipeline and has not been priced in. I personally will continue to add as and when I can as I just do not trust the silence. I cannot imagine Vlad would be so optimistic about playing a part in covid yet still have the time to go off and develop SAFE-HEMO-CAR-T and have a baby and not be finished with the research part of Covid work already.

I guess its possible they really do view this as a long term problem and are not even considering anything in 2020 and really have not spoke to anyone outside of Hemogenyx and are waiting for 2021 for a placing for funding and actually have no update to give.

The market is treating it like the latter, no imminent Covid update and not expecting CDX update soon. Fine, with nothing priced in there is very little downside and very little risk. Drilling stocks get hyped because you can see tankers rolling, mining stocks need equipment to arrive on site, assays need to be sent away. finance companies need approval or have court cases. Small pharma dont have those tell tale indicators that update is imminent.

As much as I agree that i want to see Hemo's work on Covid19, the sheer lack of communication is very telling. They said early on they had blood from early patients in New York and were going to use these to identify antibodies etc, then there was a placing and since then radio silence except Vlad saying nothing was on hold and that Hemo will play a part in the fight against Covid.

Contrast that to the work against AML, ALL, Lupus etc.
There we get updates saying looking good, seems to work, proven in vivo, proven in vitro etc. Discussions with global pharma, development agreement, licencing agreement etc.
Talks about AML, CDX, posters and presentations, trying to get their name out there, be seen and heard with regards to Cancer.
Tell me how much publicity Hemo have done regarding Covid19? A RNS back in April, an off the cuff remark in the live webinair and a very vague commitment on an update on twitter?

Hemogenyx is not a global pharma. They do not have the resources to do anything with any development they may have made. The cannot fund clinical trials and they cannot even afford IND application I suspect.

So Vlad is confident they will play a role in Covid, but making no efforts whatsoever to attract funding or attention..... Either they are many many months away from having anything to show or they are already well past that point and working with someone already.

I like many am very curious, but I have faith and I will wait.

Everyone must make their own decision, for me the idea of selling a share that is down, under valued, pending news, no hype/ramping or inflated share price to buy another share that is already 400% up in 3 months having lots of expected developments "priced in" seems bonkers :P
Hemo is locked up tight, there are no leaks there are no RNS just to boost SP. Research companies before you invest, if you need a director to hold your hand and constantly stroke you on the head saying its ok then Hemo is not for you.

If only Vlad pretended he liked Trump and went golfing with him we would be getting government money left right and centre :p

I think it a case of we would be happy with £1 if he sells early as well its an excellent return on investment, life changing amount. But at the same time if it happens there will be some remorse for what could have been. A few of us have done the maths and looked at comparable companies and what has happened there and know what could be. Personally I would prefer a buy out because it forces you to sell instead of having to time when to take profits etc. Your pretty much guaranteed a premium ontop of the higest price paid in the past 12 months.

Chad, I found to my dismay that 100% is not your maximum risk when you invest in CFDs
In my defence who knew that barrels of oil would go negative??? :P

Digittt - Yea, that is possible, Vlad has ALOT of shares so for him £1 per share would be enough to set him for life even though it would be dissapointing for us, I just hope that he is so attached to the company he holds out for atleast a year or so and we see closer to true value.